Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001824293-24-000009
Filing Date
2024-01-08
Accepted
2024-01-05 19:06:14
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A bidpricedeficiency-8xk.htm DEFA14A 36712
2 GRAPHIC image_0a.jpg GRAPHIC 16879
3 GRAPHIC image_8a.jpg GRAPHIC 1656
  Complete submission text file 0001824293-24-000009.txt   63607
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037 (619) 400-1171
GRI BIO, Inc. (Filer) CIK: 0001824293 (see all company filings)

EIN.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40034 | Film No.: 24517950
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)